Highly Active Antiretroviral Therapy and Increased Use of Contraceptives Among HIV-Positive Women During Expanding Access to Antiretroviral Therapy in Mbarara, Uganda
May 6, 2009
The current study examined whether prevalence of contraceptive use among HIV-positive women varied according to use of highly active antiretroviral therapy (HAART) in Mbarara, Uganda.
Data from a cross-sectional survey of 484 HIV-positive women (ages 18-50) attending Mbarara University's HIV clinic between November 2005 and June 2006 were used. Forty-five percent of the women were receiving HAART. Multivariate logistic regression was used to study the association between HAART use and contraceptive use.
In total, 45 percent of the women were sexually active in the previous three months, of which 85 percent reported using contraceptive methods. Of these, 84 percent reported using barrier contraceptive methods. Compared to women not receiving HAART, those receiving it were more than twice as likely to use contraceptive methods (adjusted odds ratio [AOR]=2.64; 95 percent confidence interval [CI]=1.07, 6.49) and more than three times as likely to use barrier contraceptive methods (AOR=3.62; 95 percent CI=1.54, 8.55).
"Our findings support the need for increased attention to better integration of reproductive health and HIV and AIDS services for women who are HIV-positive," the authors concluded.
American Journal of Public Health
02.2009; Vol. 99; No. 2: P. 340-347; Irene Andia, M.B., Ch.B.; MMed; Angela Kaida, M.Sc.; Marissa Maier, M.D.; David Guzman, M.S.P.H.; Nneka Emenyonu, M.P.H.; Larry Pepper, D.O., M.S.P.M.; David R. Bangsberg, M.D., M.P.H.; Robert S. Hogg, Ph.D.
Shortage of HIV/AIDS, TB, Malaria Drugs in Ugandan District Could Lead to Treatment Interruption, Drug Resistance
This article was provided by U.S. Centers for Disease Control and Prevention. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update. Visit the CDC's website to find out more about their activities, publications and services.